JPS5024216B1 - - Google Patents

Info

Publication number
JPS5024216B1
JPS5024216B1 JP13054970A JP13054970A JPS5024216B1 JP S5024216 B1 JPS5024216 B1 JP S5024216B1 JP 13054970 A JP13054970 A JP 13054970A JP 13054970 A JP13054970 A JP 13054970A JP S5024216 B1 JPS5024216 B1 JP S5024216B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13054970A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP13054970A priority Critical patent/JPS5024216B1/ja
Publication of JPS5024216B1 publication Critical patent/JPS5024216B1/ja
Application status is Pending legal-status Critical

Links

JP13054970A 1970-12-29 1970-12-29 Pending JPS5024216B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13054970A JPS5024216B1 (en) 1970-12-29 1970-12-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13054970A JPS5024216B1 (en) 1970-12-29 1970-12-29

Publications (1)

Publication Number Publication Date
JPS5024216B1 true JPS5024216B1 (en) 1975-08-14

Family

ID=15036923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13054970A Pending JPS5024216B1 (en) 1970-12-29 1970-12-29

Country Status (1)

Country Link
JP (1) JPS5024216B1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52136719U (en) * 1976-04-13 1977-10-17
JPS61164779U (en) * 1985-04-02 1986-10-13
JPH0254578U (en) * 1988-10-12 1990-04-19
US9629804B2 (en) 2013-10-22 2017-04-25 Shire Human Genetic Therapies, Inc. Lipid formulations for delivery of messenger RNA
US9713626B2 (en) 2013-03-14 2017-07-25 Rana Therapeutics, Inc. CFTR mRNA compositions and related methods and uses
US9850269B2 (en) 2014-04-25 2017-12-26 Translate Bio, Inc. Methods for purification of messenger RNA
US10138213B2 (en) 2014-06-24 2018-11-27 Translate Bio, Inc. Stereochemically enriched compositions for delivery of nucleic acids

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52136719U (en) * 1976-04-13 1977-10-17
JPS61164779U (en) * 1985-04-02 1986-10-13
JPH0254578U (en) * 1988-10-12 1990-04-19
US9713626B2 (en) 2013-03-14 2017-07-25 Rana Therapeutics, Inc. CFTR mRNA compositions and related methods and uses
US9629804B2 (en) 2013-10-22 2017-04-25 Shire Human Genetic Therapies, Inc. Lipid formulations for delivery of messenger RNA
US10052284B2 (en) 2013-10-22 2018-08-21 Translate Bio, Inc. Lipid formulations for delivery of messenger RNA
US9850269B2 (en) 2014-04-25 2017-12-26 Translate Bio, Inc. Methods for purification of messenger RNA
US10155785B2 (en) 2014-04-25 2018-12-18 Translate Bio, Inc. Methods for purification of messenger RNA
US10138213B2 (en) 2014-06-24 2018-11-27 Translate Bio, Inc. Stereochemically enriched compositions for delivery of nucleic acids

Similar Documents

Publication Publication Date Title
AU424035B2 (en)
AU423135B2 (en)
AU423794B2 (en)
AU431153B2 (en)
AU3398071A (en)
AU419965B2 (en)
AU416589B2 (en)
AU432607B2 (en)
AU417008B2 (en)
AU1065270A (en)
AU414415B2 (en)
AU411530B2 (en)
AU432936B2 (en)
AU1326870A (en)
AU432588B2 (en)
AU414408B2 (en)
AU3291671A (en)
AU431508B2 (en)
AU1609670A (en)
AU433381B2 (en)
AU431646B2 (en)
AU421245B2 (en)
AU418406B2 (en)
AU427631B2 (en)
AU422072B2 (en)